Nanjing Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Retailing
  • ISIN: CNE000000KV1
CNY
5.19
-0.03 (-0.57%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
53,579.90
53,482.07
50,105.01
45,031.83
39,743.61
37,089.34
31,238.01
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
53,579.90
53,482.07
50,105.01
45,031.83
39,743.61
37,089.34
31,238.01
Raw Material Cost
50,593.16
50,551.07
47,226.32
42,437.21
37,444.78
34,838.80
29,357.49
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
529.19
544.89
446.58
455.01
372.06
439.70
359.51
Selling and Distribution Expenses
1,444.17
1,405.37
1,488.21
1,274.90
1,248.10
1,249.63
1,083.90
Other Expenses
-50.51
-51.75
-42.83
-44.32
-36.39
-43.29
-35.44
Total Expenditure (Excl Depreciation)
52,061.46
51,983.80
48,732.83
43,723.93
38,701.05
36,095.27
30,446.45
Operating Profit (PBDIT) excl Other Income
1518.4
1498.3000000000002
1372.2
1307.8999999999999
1042.6000000000001
994.0999999999999
791.5999999999999
Other Income
21.94
24.49
-17.89
-15.83
7.39
81.82
40.97
Operating Profit (PBDIT)
1,800.36
1,798.40
1,619.59
1,534.89
1,197.67
1,223.81
959.77
Interest
529.19
544.89
446.58
455.01
372.06
439.70
359.51
Exceptional Items
9.89
0.23
3.35
13.12
28.03
-42.07
6.73
Gross Profit (PBDT)
2,986.74
2,931.00
2,878.69
2,594.62
2,298.83
2,250.55
1,880.53
Depreciation
278.24
281.73
269.83
251.23
158.63
147.28
126.98
Profit Before Tax
1,002.81
972.01
906.53
841.77
695.01
594.76
480.01
Tax
260.28
265.26
190.09
228.31
207.76
157.32
129.96
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
570.63
577.83
595.67
505.18
376.41
346.92
264.29
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
570.63
577.83
595.67
505.18
376.41
346.92
264.29
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
172.49
134.98
120.25
105.37
93.62
84.63
81.54
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
743.12
712.81
715.92
610.55
470.04
431.55
345.83
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,829.09
6,435.19
5,999.86
4,606.31
4,257.54
4,013.57
3,677.73
Earnings per share (EPS)
0.44
0.45
0.47
0.48
0.36
0.33
0.25
Diluted Earnings per share
0.44
0.45
0.47
0.48
0.36
0.33
0.25
Operating Profit Margin (Excl OI)
2.8%
2.79%
2.73%
2.89%
2.6%
2.68%
2.53%
Gross Profit Margin
2.39%
2.34%
2.35%
2.43%
2.15%
2.0%
1.94%
PAT Margin
1.07%
1.08%
1.19%
1.12%
0.95%
0.94%
0.85%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 0.18% vs 6.74% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 4.25% vs -0.43% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 0.25% vs 8.33% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -2.88% vs 22.01% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Nanjing Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
53,579.90
0
53,579.90
Other Operating Income
0.00
0.00
0.00
Total Operating income
53,579.90
0
53,579.90
Raw Material Cost
50,593.16
0
50,593.16
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
529.19
0
529.19
Selling and Distribution Expenses
1,444.17
0
1,444.17
Other Expenses
-50.51
0.00
-50.51
Total Expenditure (Excl Depreciation)
52,061.46
0
52,061.46
Operating Profit (PBDIT) excl Other Income
1,518.44
0.00
1,518.44
Other Income
21.94
0
21.94
Operating Profit (PBDIT)
1,800.36
0
1,800.36
Interest
529.19
0
529.19
Exceptional Items
9.89
0
9.89
Gross Profit (PBDT)
2,986.74
0
2,986.74
Depreciation
278.24
0
278.24
Profit Before Tax
1,002.81
0
1,002.81
Tax
260.28
0
260.28
Provisions and contingencies
0
0
0.00
Profit After Tax
570.63
0
570.63
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
570.63
0
570.63
Share in Profit of Associates
0
0
0.00
Minority Interest
172.49
0
172.49
Other related items
0.00
0.00
0.00
Consolidated Net Profit
743.12
0
743.12
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,829.09
0
6,829.09
Earnings per share (EPS)
0.44
0
0.44
Diluted Earnings per share
0.44
0
0.44
Operating Profit Margin (Excl OI)
2.80%
0%
0.00
2.80%
Gross Profit Margin
2.39%
0%
0.00
2.39%
PAT Margin
1.07%
0%
0.00
1.07%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 5,357.99 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.18% vs 6.74% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 74.31 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 4.25% vs -0.43% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 177.84 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.25% vs 8.33% in Dec 2023

Annual - Interest
Interest 52.92 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -2.88% vs 22.01% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.80%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023